Citadel Advisors’s Quipt Home Medical QIPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,500
Closed -$8.15K 14595
2025
Q1
$8.15K Sell
3,500
-8,800
-72% -$24.1K ﹤0.01% 13656
2024
Q4
$37.5K Buy
12,300
+1,100
+10% +$2.96K ﹤0.01% 12667
2024
Q3
$32.7K Buy
11,200
+9,900
+762% +$30.6K ﹤0.01% 12354
2024
Q2
$4.19K Sell
1,300
-2,000
-61% -$7.18K ﹤0.01% 13508
2024
Q1
$14.4K Sell
3,300
-5,300
-62% -$23.9K ﹤0.01% 13245
2023
Q4
$43.8K Sell
8,600
-16,500
-66% -$79K ﹤0.01% 11920
2023
Q3
$128K Sell
25,100
-3,100
-11% -$16.6K ﹤0.01% 10591
2023
Q2
$151K Buy
28,200
+26,700
+1,780% +$158K ﹤0.01% 10332
2023
Q1
$10.5K Buy
+1,500
New +$9.24K ﹤0.01% 13525
2022
Q3
Sell
-12,800
Closed -$59K 13418
2022
Q2
$59K Buy
+12,800
New +$59K ﹤0.01% 11827

Citadel Advisors's QIPT Position: Q1 2026 in Review

Citadel Advisors sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 73,672 shares — an estimated $260K sold.

Citadel Advisors first reported a position in QIPT in Q4 2021 and held it in 16 quarters. The position peaked at $928K in Q2 2023. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.

  • Citadel Advisors reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 73,672 Quipt Home Medical shares in Q1 2026, an estimated $260K.
  • Citadel Advisors first reported a position in Quipt Home Medical in Q4 2021 and held it in 16 quarters.
  • Citadel Advisors's Quipt Home Medical position peaked at $928K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.